Abstract
The development of medicine is based not only on the introduction of new methods of treatment, but also on the use of increasingly effective drugs, including antithrombotic drugs. Drugs that inhibit the activity of platelets (antiplatelet and anti-aggregating drugs) and pharmaceuticals that inhibit the activity of plasma coagulation factors (anticoagulants) are used in antithrombotic therapy. In our daily practice we encounter patients who take chronic antiplatelet or anticoagulant drugs. However, more and more often we are dealing with patients who are treated with two antiplatelet drugs, an antiplatelet and an anticoagulant or even undergoing triple antithrombotic therapy. When preparing the patient for invasive craniofacial procedures, it should be assessed whether the temporary discontinuation of antithrombotic treatment due to the fear of excessive perioperative bleeding is justified and will not result in life-threatening thromboembolic complications. The authors discuss in detail the medications used in modern antithrombotic treatment and present a perioperative management procedure with a patient who takes l4 z of these medications chronically.
Subject
Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health
Reference27 articles.
1. Dental cardio common position for dealing anticoagulation in patients undergoing dental procedures;Pruszczyk;Kardiol. Pol.,2016
2. Perioperative management of anticoagulant and antiplatelet therapy;Tafur;Heart,2018
3. Perioperative management of antithrombotic therapy: A case-based narrative review;Chen;Intern. Emerg. Med.,2022
4. Functional implant prosthodontic score of a one-year prospective study on three different connections for single-implant restorations;Carboncini;J. Osseointegration,2018
5. Newer concepts of blood coagulation;Lee;Haemophilia,1998
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献